[1] Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts[J]. Science, 1998, 282:1145-1147. [2] Dejosez M, Zwaka TP. Pluripotency and Nuclear Reprogramming[J]. Annu Rev Biochem, 2012, 81:737-765. [3] Wickramasinghe VO, Laskey RA. Control of mammalian gene expression by selective mRNA export[J]. Nat Rev Mol Cell Biol, 2015, 16:431-442. [4] Bachi A, Braun IC, Rodrigues JP, et al. The C-terminal domain of TAP interacts with the nuclear pore complex and promotes export of specific CTE-bearing RNA substrates[J]. RNA, 1999, 6:136-158. [5] Ma ASW, Moran-Jones K, Shan J, et al. Heterogeneous nuclear ribonucleoprotein A3, a novel RNA trafficking response element-binding protein[J]. J Biol Chem, 2002, 277:18010-18020. [6] Gebhardt A, Habjan M, Benda C, et al. mRNA export through an additional cap-binding complex consisting of NCBP1 and NCBP3[J]. Nat Commun, 2015,6:81-92. [7] Madara R, Archer SK, Dent CI, et al. SRSF3 promotes pluripotency through Nanog mRNA export and coordina-tion of the pluripotency gene expression program[J]. Elife, 2018, 7:e37419. doi: 10.7554/eLife.37419. [8] Wang L, Miao YL, Zheng X, et al. The THO complex regulates pluripotency gene mRNA export and controls embryonic stem cell self-renewal and somatic cell reprogramming[J]. Cell Stem Cell, 2013, 13:676-690. [9] Niwa H, Miyazaki JI, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells[J]. Nat Genet, 2000, 24:372-376. [10] Buckley S, Aranda OB, Strikoudis A, et al. Regulation of pluripotency and cellular reprogramming by the ubiquitin-proteasome system[J]. Cell Stem Cell, 2012, 11:783-798. [11] Guttman M, Donaghey J, Carey BW, et al. lincRNAs act in the circuitry controlling pluripotency and differentiation[J]. Nature, 2011, 477:295-300. [12] Kim J, Chu J, Shen X, et al. An extended transcriptional network for pluripotency of embryonic stem cells[J]. Cell, 2008, 132:1049-1061. |